Literature DB >> 2660681

Physicochemical aspects of heparin cofactor II.

C W Pratt1, H C Whinna, J B Meade, R E Treanor, F C Church.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2660681     DOI： 10.1111/j.1749-6632.1989.tb22494.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers.

Authors:  J Dawes; M McLaren; C Forbes; J J Belch; D A Lane; B Bray; J McEwen; G Houin; F Gianese
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

2.  Suggestions on leading an academic research laboratory group.

Authors:  Frank C Church
Journal:  Open Life Sci       Date:  2022-06-15       Impact factor: 1.311

3.  Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.

Authors:  G Mascellani; L Liverani; P Bianchini; B Parma; G Torri; A Bisio; M Guerrini; B Casu
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

4.  Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.

Authors:  H C Whinna; F C Church
Journal:  J Protein Chem       Date:  1993-12

5.  The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system.

Authors:  J Hogwood; A Naggi; G Torri; C Page; P Rigsby; B Mulloy; E Gray
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.